Neutral Citation Number : 2023/DHC/000515

C.A.(COMM.IPD-PAT) 22/2021 Page 1 of 34

$~39(Original)

*

IN THE HIGH COURT OF DELHI AT NEW DELHI

+

C.A.(COMM.IPD-PAT) 22/2021

ALLERGAN INC

..... Appellant

Through:

Mr.

Ankush

Verma,

Mr.Debashish Banerjee, Mr. Vineet Rohilla,

Mr.Rohit

Rangi,

Mr.Venkatesh

Naik,

Mr.Tanveer Malhotra, Advs.

versus

THE CONTROLLER OF PATENTS

..... Respondent

Through:

Mr.

Harish

Vaidyanathan

Shankar, CGSC, Mr. Srish Kumar Mishra,

Mr. Sagar Mehlawat, Mr. Alexander Mathai

Paikaday, Advs.

CORAM:

HON'BLE MR. JUSTICE C.HARI SHANKAR

J U D G M E N T (O R A L)

%

20.01.2023

1.

On 13^th August 2012, the appellant submitted Patent

Application No. 7039/DELNP/2012 to the Patent Office, New Delhi,

for grant of a patent for “INTRACAMERAL SUSTAINED

RELEASE THERAPEUTIC AGENT IMPLANTS”. The application

contained the following 20 claims:

“1.

A method for treating an ocular condition comprising the

steps of:

providing at least two biodegradable sustained release

implants containing at least one therapeutic agent;

implanting the at least two biodegradabl